BCL2L1 and breast carcinoma: The four HA‐tagged Bcl‐xL mutants, R132W, N136K, R165W, and A201T, were transfected into a packaging cell line and the viral supernatants were collected to infect MCF7/TGL breast cancer cells, which has low levels of endogenous Bcl‐xL.